Hepato-Pancreatico-Biliary Surgery

The Division of Hepato-Pancreatico-Biliary Surgery is dedicated to treating all conditions of the liver, biliary system, and pancreas and is recognized for its clinical and basic science research. Our HPB team works in close collaboration with the medical oncology team at the MUSC Hollings Cancer Center, a national leader in cancers of the digestive system, including the colon, pancreas, liver, stomach, biliary tree and rectum. Our surgeons are nationally-recognized experts in the treatment of chronic pancreatitis and islet cell transplantation. MUSC surgeons have performed more than 275 islet cell transplant procedures since the program’s inception in 2009 and our program is ranked the #2 islet cell transplant program in the world. MUSC researchers received a $1.68 million National Institutes of Health grant to explore a better treatment for chronic pancreatitis. 

MUSC is a National Pancreas Foundation-designated Pancreas Center of Excellence. National Pancreas Foundation Centers of Excellence are at premier healthcare facilities that focus on multidisciplinary treatment of pancreas disease, treating the “whole patient” with a focus on the best possible outcomes and improved quality of life.

Meet our faculty and learn about their areas of expertise:

 

Katherine Morgan, M.D.

Chief & Professor of Surgery
Clinical Director of the Islet Transplant Program

 

William Lancaster, M.D.

Associate Professor of Surgery
Associate Medical Director of the CCT

 

David Mahvi, M.D.

Professor of Surgery

Research Faculty:

 

Hongjun Wang, Ph.D.

Professor of Surgery

 

Meenal Mehrotra, M.D., Ph.D.

Assistant Professor of Surgery